Being immunocompromised or in close contact with an infected person puts vaccinated people at a higher risk of infection, ...

Exciting new research by Baker Heart and Diabetes Institute researchers raises the possibility that we could reduce the severity of heart failure and ...

The FDA has granted fast-track designation to nipocalimab for the treatment of Sjögren’s disease, according to a press ...

Zhittya Genesis Medicine proudly announces that Dr. Jack Jacobs, President and Chief Science Officer, will be honored by NevadaBio at its Annual Awards Dinner on Wednesday, April 2, 2025, at 5:30 pm ...

The convergence of AI and drug delivery is opening new frontiers in precision medicine. AI-powered predictive modeling is ...

Breakthrough T1D Canada is calling on the Quebec government to adopt the 2022 INESSS recommendation to eliminate current age restrictions on public coverage of insulin pumps and extend access to all ...

Scientists have made a potentially “life-changing” discovery that could pave the way for new drugs to treat Parkinson’s ...

Scientists have made a major breakthrough for early diagnosis of a brain disorder afflicting some of Australia's football ...

FDA grants Fast Track designation to Johnson & Johnson’s investigational therapy nipocalimab for the treatment of moderate-to-severe Sjögren’s disease, which could be the first targeted therapy ever ...

Researchers have discovered more about PINK1, a protein that’s directly tied to Parkinson’s disease. A team from Walter and Eliza Hall Institute in Australia has shown how the protein attaches to cell ...